Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: J Neurol. 2018 Jul 30;265(10):2267–2276. doi: 10.1007/s00415-018-8981-x

Fig 3.

Fig 3.

Associations between vasoreactivity and gait measures in participants with T2DM.

Lower cerebral vasoreactivity is associated with slower gait speed during NW (a) and DTW (b) and greater decreases in gait speed during NW (c) and DTW (d) in the diabetic group. Lower cerebral vasoreactivity is associated with higher dual-task costs during walking (e). Duration of diabetes is associated with greater decrease in gait speed during NW (f). In the control group, no similar association was observed. Best fit = red solid line; confidence interval = red dotted lines; mean = blue dotted line.